Literature DB >> 12021433

Structural features of interferon-gamma aggregation revealed by hydrogen exchange.

Scott A Tobler1, Erik J Fernandez.   

Abstract

Using hydrogen-deuterium exchange (HX) and electrospray ionization mass spectrometry, we have investigated the stability and structural changes of recombinant human interferon-gamma (IFN-gamma) during aggregation induced by guanidine hydrochloride (GdnHCl) and potassium thiocyanate. First, HX labeling was initiated after the amorphous aggregates were formed to probe the tertiary structure of the aggregated state. Second, labeling was performed at low protein concentrations to assess stability under aggregation prone conditions. In 1 M GdnHCl, the stability of IFN-gamma was greatly reduced and much less protection from HX in solution was observed. Exchange under these conditions was slower in helix C than in the rest of the protein. Aggregates formed in 1 M GdnHCl showed a HX pattern consistent with a partially unfolded state with an intact helix C. Although aggregates formed in 0.3 M KSCN exhibited a HX pattern similar to those formed in GdnHCl, the solution phase HX pattern in 0.3 M KSCN was surprisingly comparable to that of the native state. Varying the aggregation time before performing HX revealed that KSCN first precipitated native protein and then facilitated partial unfolding of the precipitated protein. These results show that helix C, which forms the hydrophobic core of the IFN-gamma dimer, is highly protected from HX under native conditions, is more stable in GdnHCl than the rest of the protein and remains intact in both GdnHCl- and KSCN-induced aggregates. This suggests that native-state HX patterns may presage regions of the protein susceptible to unfolding during aggregation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021433      PMCID: PMC2373637          DOI: 10.1110/ps.3770102

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  50 in total

1.  Probing residue-level unfolding during lysozyme precipitation.

Authors:  S T Chang; E J Fernandez
Journal:  Biotechnol Bioeng       Date:  1998-07-20       Impact factor: 4.530

2.  Protein stability: electrostatics and compact denatured states.

Authors:  D Stigter; D O Alonso; K A Dill
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition.

Authors:  M A Speed; D I Wang; J King
Journal:  Nat Biotechnol       Date:  1996-10       Impact factor: 54.908

Review 4.  Protein aggregation: folding aggregates, inclusion bodies and amyloid.

Authors:  A L Fink
Journal:  Fold Des       Date:  1998

Review 5.  The molecular basis of amyloidosis.

Authors:  L C Serpell; M Sunde; C C Blake
Journal:  Cell Mol Life Sci       Date:  1997-12       Impact factor: 9.261

6.  Probing the non-covalent structure of proteins by amide hydrogen exchange and mass spectrometry.

Authors:  D L Smith; Y Deng; Z Zhang
Journal:  J Mass Spectrom       Date:  1997-02       Impact factor: 1.982

Review 7.  Hydrogen exchange: the modern legacy of Linderstrøm-Lang.

Authors:  S W Englander; L Mayne; Y Bai; T R Sosnick
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

8.  Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor.

Authors:  M R Walter; W T Windsor; T L Nagabhushan; D J Lundell; C A Lunn; P J Zauodny; S K Narula
Journal:  Nature       Date:  1995-07-20       Impact factor: 49.962

Review 9.  Mutations and off-pathway aggregation of proteins.

Authors:  R Wetzel
Journal:  Trends Biotechnol       Date:  1994-05       Impact factor: 19.536

10.  1H, 13C, and 15N NMR backbone assignments and secondary structure of human interferon-gamma.

Authors:  S Grzesiek; H Döbeli; R Gentz; G Garotta; A M Labhardt; A Bax
Journal:  Biochemistry       Date:  1992-09-08       Impact factor: 3.162

View more
  7 in total

1.  Protein thermal aggregation involves distinct regions: sequential events in the heat-induced unfolding and aggregation of hemoglobin.

Authors:  Yong-Bin Yan; Qi Wang; Hua-Wei He; Hai-Meng Zhou
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

Review 2.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Guanbo Wang; Burcu Baykal; Shunhai Wang
Journal:  Biotechnol Adv       Date:  2011-05-17       Impact factor: 14.227

3.  Enhanced correction methods for hydrogen exchange-mass spectrometric studies of amyloid fibrils.

Authors:  Indu Kheterpal; Ronald Wetzel; Kelsey D Cook
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

4.  Changes in solvent exposure reveal the kinetics and equilibria of adsorbed protein unfolding in hydrophobic interaction chromatography.

Authors:  R W Deitcher; J P O'Connell; E J Fernandez
Journal:  J Chromatogr A       Date:  2010-06-25       Impact factor: 4.759

5.  Simultaneous monitoring of peptide aggregate distributions, structure, and kinetics using amide hydrogen exchange: application to Abeta(1-40) fibrillogenesis.

Authors:  Wei Qi; Aming Zhang; Dhara Patel; Sungmun Lee; Jamie L Harrington; Liming Zhao; David Schaefer; Theresa A Good; Erik J Fernandez
Journal:  Biotechnol Bioeng       Date:  2008-08-15       Impact factor: 4.530

6.  Recombinant IFN-γ from the bank vole Myodes glareolus: a novel tool for research on rodent reservoirs of zoonotic pathogens.

Authors:  Francesca Torelli; Steffen Zander; Heinz Ellerbrok; Georg Kochs; Rainer G Ulrich; Christian Klotz; Frank Seeber
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

7.  Chiral sum frequency generation for in situ probing proton exchange in antiparallel β-sheets at interfaces.

Authors:  Li Fu; Dequan Xiao; Zhuguang Wang; Victor S Batista; Elsa C Y Yan
Journal:  J Am Chem Soc       Date:  2013-02-19       Impact factor: 16.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.